Sequential liver and haematopoietic stem cell transplantation in a case of fulminant hepatitis associated liver failure and aplastic anaemia.
Zeyad Al-ShaibaniSreelakshmi KothaWilson LamZita GalvinLeslie LillyJeffrey H LiptonArjun Datt LawPublished in: European journal of haematology (2019)
The management of severe aplastic anaemia is particularly challenging when it occurs in the context of recent liver transplantation. Rapid identification of a suitable donor followed by allogeneic haematopoietic stem cell transplantation is the only curative option. This scenario is often complicated by potentially life-threatening infections that develop as a consequence of immunosuppression. Alternative donor transplantation using suitably matched unrelated donors can be potentially life-saving when suitably matched sibling donors are unavailable. Above all, a dedicated interdisciplinary approach with seamless communication between hepatology, transplant surgery, haematology, and stem cell transplant services is essential to achieving optimal outcomes. Herein, we describe a case of severe hepatitis leading to hepatic failure who was treated with liver transplantation from a deceased donor, and later received an allogeneic haematopoietic stem cell transplantation from a matched unrelated donor for hepatitis-associated aplastic anaemia.
Keyphrases
- stem cell transplantation
- high dose
- liver failure
- stem cells
- allogeneic hematopoietic stem cell transplantation
- kidney transplantation
- hepatitis b virus
- minimally invasive
- early onset
- healthcare
- primary care
- mental health
- low dose
- cord blood
- coronary artery bypass
- adipose tissue
- acute lymphoblastic leukemia
- acute myeloid leukemia
- drug induced
- newly diagnosed
- mesenchymal stem cells
- bioinformatics analysis